On the 15th, it was reported that medical experts from Shanghai, Beijing, and Guangdong provinces have jointly conducted a global study on pediatric cardiovascular disease. The results show that in the past 30 years, thanks to the advancement of congenital heart disease (CHD) diagnosis and treatment technology and the popularization of prenatal screening systems, the overall mortality rate of pediatric cardiovascular disease worldwide has decreased by 55%, and the treatment of congenital heart disease has achieved significant results. Research has shown that in sharp contrast to the effectiveness of treating congenital heart disease, the scale of non congenital cardiovascular disease (NC-CVD) continues to expand, with the number of cases increasing by about one-third since 1992, indicating that the pressure of prevention and control of childhood acquired cardiovascular disease is constantly rising. This study, conducted by the National Children's Medical Center, Shanghai Children's Medical Center affiliated with Shanghai Jiao Tong University School of Medicine, Peking University Institute of Child and Adolescent Health, and Guangdong Provincial People's Hospital, is based on the Global Burden of Disease (GBD) big data. It systematically reveals the epidemiological evolution of cardiovascular diseases in children in 204 countries and regions worldwide from 1992 to 2021, providing key scientific basis for the adjustment of global strategies for the prevention and control of cardiovascular diseases in children. Their research findings were published online in the internationally authoritative journal Communications Medicine. It is reported that it is noteworthy that the study further found that the global incidence rate of non congenital cardiovascular diseases has accelerated after 2019. The mortality rate of cardiovascular disease in children in countries with low Social Population Index (SDI) is about 8 times higher than that in countries with high SDI. The study points out that this gap deeply reflects the significant impact of differences in medical resource allocation on disease prognosis, providing important reference for the balanced allocation of global medical resources. It is reported that in the comparative analysis of disease spectrum characteristics in different countries, the study highlights the differences between China and high-income countries. High SDI countries, represented by the United States, are currently facing challenges from non congenital diseases such as myocarditis; As a representative of medium SDI countries, the main challenge currently faced by China lies in the early accumulation of cardiovascular metabolic risk. Long term data shows that the cardiovascular metabolic risk of Chinese adolescents is rapidly increasing, with high BMI (obesity) growing the fastest. Unhealthy dietary structure and other factors constitute the core factors that increase the burden of cardiovascular disease in Chinese children. This research provides a clear direction for optimizing prevention and control strategies in the pediatric cardiovascular field. The research team stated that in the future, on the basis of continuously consolidating the achievements in the prevention and treatment of congenital heart disease, it is necessary to gradually extend the focus of prevention and control to non congenital diseases such as myocarditis, cardiomyopathy, and hypertension, strengthen the development and implementation of early screening and comprehensive intervention strategies, and comprehensively protect the cardiovascular health of children and adolescents. (New Society)